The Coca-Cola Company
10
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
The Energy Flux Study
Role: collaborator
SATIN: Satiety Innovation. Study 2- University of Aberdeen
Role: collaborator
Effects of Low Calorie Sweeteners on Dietary Intakes, Hunger, Appetite and Satiety
Role: lead
Parent-targeted Mobile Phone Based Intervention to Increase Physical Activity in Children (P-Mobile)
Role: collaborator
International Study of Childhood Obesity, Lifestyle and the Environment
Role: collaborator
High Intensity Interval Versus Continuous Moderate Intensity Training: Maximizing the Benefits of Exercise in Overweight Adolescents
Role: collaborator
Satiety Innovation- Study 793. University of Aberdeen
Role: collaborator
Evaluation of a New Orange-Based Beverage Enriched With Polyphenols in Adult Humans
Role: lead
Effect of Coca-Cola on Iron Absorption
Role: collaborator
Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink
Role: collaborator
All 10 trials loaded